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The correction 
of conjunctivochalasis using 
high‑frequency radiowave 
electrosurgery improves dry eye 
disease
Yong Woo Ji1,2, Hyojin Seong1,2, Sujung Lee3, Mutlaq Hamad Alotaibi2,5, Tae‑im Kim2,4, 
Hyung Keun Lee2,4 & Kyoung Yul Seo2*
We aimed to determine the clinical impact of conjunctivochalasis (CCh) and its correction using high‑
frequency radiowave electrosurgery (HFR‑ES), for signs and symptoms of dry eye disease (DED). Forty 
patients diagnosed with symptomatic CCh were prospectively enrolled. As a result, patients with 
CCh had moderate to severe DED and most of them exhibited meibomian gland dysfunction (MGD). 
Corneo‑conjunctival fluorescein staining score (CFS) and all lid‑parallel‑conjunctival‑folds scores 
(LIPCOFs) were positively correlated. Nasal LIPCOF significantly correlated with symptoms and tear 
volume. Central, temporal, and total LIPCOF significantly correlated with MG loss, MGD stage, and 
lipid layer thickness. Independent significant factors associated with total LIPCOF included CFS, tear 
break‑up time, and MGD stage. One month following HFR‑ES, CCh was completely resolved in all 
cases. Patient age and preoperative nasal LIPCOF were determinants of outcomes associated with 
postoperative improvements in symptoms. Ocular surface parameters significantly improved, but 
MGD‑related signs did not. Collectively, CCh associated with MGD severity deteriorates not only tear 
film stability and reservoir capacity, leading to DED exacerbation. Therefore, CCh should be corrected 
in patients with DED and MGD. Younger patients with nasal CCh are likely to experience more 




HFR-ES  High-frequency radiowave electrosurgery
DED  Dry eye disease
OSDI  Ocular surface disease index
CFS  Corneo-conjunctival fluorescein staining
TBUT  Tear break-up time
TMA  Tear meniscus cross-sectional area
LIPCOF  Lid parallel conjunctival folds
MGD  Meibomian gland dysfunction
MGL  Meibomian gland loss
LLT  Lipid layer thickness
AS-OCT  Anterior segment optical computed tomography
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ATD  Aqueous tear deficiency
LTD  Lipid tear deficiency
Conjunctivochalasis (CCh) is a chronic condition of the ocular surface (OS), and its prevalence increases with 
 age1,2. CCh is most common in elderly individuals and is one of the most common co-morbid conditions in 
patients with dry eye disease (DED)3–10. CCh comprises redundant conjunctival folds characterized by loose and 
non-edematous bulbar conjunctiva that accumulate between the eyeball and the eyelid  margin2,11. CCh is often 
found between the globe and lower eyelid, but in severe cases can be observed in the superior and even the whole 
bulbar  conjunctiva2,12. CCh has been thought to be caused by elastic fiber degradation involving inflammatory 
factors or mechanical interference with conjunctival lymphatic  circulation13–15. Recently, CCh is considered to 
be one of the friction-related diseases (FRD), which also include superior limbic keratoconjunctivitis and lid 
wiper  epitheliopathy16.
Previous studies demonstrated that the presence of CCh exhibits a strong positive predictive value in the 
diagnosis of  DED8,10. Furthermore, CCh can symptomatically mimic DED, since it negatively affects the stability, 
distribution, and clearance of tear  film2,4,6,17,18. The mechanistic relationship of CCh to DED severity depends on 
the friction induced by blinking and low tear  volume7,16,19. Moreover, DED signs and symptoms are more severe 
when meibomian gland dysfunction (MGD) coexists with FRDs such as  CCh5,16.
CCh causes not only epiphora and ocular discomfort, but also adversely impacts vision-related quality of life 
due to the highly unstable tear  film20. Accordingly, symptomatic CCh should be treated following an attentive 
diagnosis. Clinicians have used anterior segment optical computed tomography (AS-OCT) as well as routine 
slit-lamp biomicroscopy to inspect conjunctival  folds3,10,12. The first-line treatment for CCh is medical therapy, 
including use of OS lubricant and anti-inflammatory  eyedrops21. However, in advanced cases, to alleviate ocular 
signs and symptoms of DED, surgical approaches such as excision, cauterization, or high-frequency radiowave 
electrosurgery (HFR-ES) should be  considered12,21–25.
In this study, we aimed to investigate the clinical impact of CCh and its correction using HFR-ES (Fig. 1), 
with regard to the signs and symptoms of DED. Furthermore, to provide information for proper management 
after surgery, we determined the factors associated with the CCh severity and symptom relief following HFR-ES.
Results
Forty eyes (40 patients) with symptomatic CCh were prospectively enrolled. The mean age of patients was 
61.65 ± 12.39 years, and 40% were women. lid-parallel conjunctival folds (LIPCOF) scores were representative of 
CCh (nasal, 2.28 ± 0.64; central, 0.85 ± 0.98; temporal, 2.10 ± 0.81; total, 5.23 ± 1.82). Table 1 shows that patients 
enrolled in the present study had moderate to severe DED (OS Disease Index (OSDI), 42.65 ± 19.88; tear film 
break-up time (TBUT), 1.83 ± .55 s; corneo-conjunctival fluorescein staining score (CFS), 1.43 ± .50) and 82.5% 
of them had MGD (MGD stage, 1.60 ± 1.53; meibomian gland loss (MGL) grade, 1.45 ± 1.36). Moreover, tear 
meniscus cross-sectional areas (TMAs) at all regions of the lower lid margin were low (nasal,.0045 ± .0051  mm2; 
central, .0103 ± .0086 mm2; temporal, .0061 ± .0059 mm2) (Table 1).
Correlation between CCh and ocular surface parameters and investigation of clinical deter‑
minants associated with the severity of CCh. We first investigated which ocular surface parameters 
had pathological relationships to CCh. Correlation analysis revealed a strong positive correlation between nasal 
LIPCOF and OSDI score (r = .500 and P = .001, Fig. 2a). In addition, nasal LIPCOF score negatively correlated 
with nasal and temporal TMAs (r =  − .415, − .325 and P = .004, .020, respectively), but positively correlated with 
central TMA (r = .440 and P = .002, Fig. 2a). Nasal LIPCOF was not significantly correlated with TBUT, while 
central, temporal, and total LIPCOF were significantly correlated (r =  − .151, − .720, − .651, 729, and P = .176, 
< .001, < .001, < .001, respectively, Fig. 2b–d). Central and temporal as well as total LIPCOF were significantly 
related to MGD-related factors, including MGL grade, MGD stage, and lipid layer thickness (LLT) (Fig. 2b–d). 
There was a positive correlation between CFS and all LIPCOFs (Fig. 2).
Next, we explored which clinical determinants were associated with CCh severity. Since all clinical signs or 
measurements for DED and MGD reflected the whole area of OS or MG, we analyzed factors associated with 
total LIPCOF score using multiple mixed linear regression. Interestingly, multivariable analysis revealed that 
significant independent factors associated with total LIPCOF included CFS, TBUT, and MGD stage (β = .416, 
− .434, .222 and P =  < .001, .001, < .046, respectively). However, our analysis showed MGL grade and LLT did 
not affect total LIPCOF (P = .962 and .326, respectively), inconsistent with the correlation analysis displayed in 
Fig. 2 (Table 2).
Effect of CCh correction on ocular surface signs and symptoms. To ameliorate the OS environment 
disturbed by CCh, we performed HFR-ES for symptomatic CCh patients according to our previous method 
(Fig.  1)24,25. All surgeries were uneventful, and no significant postoperative complication was noted. At one 
month after HFR-ES, we confirmed complete elimination of CCh in all cases using slit-lamp biomicroscopic 
examination (Fig. 3a). AS-OCT also identified recovery of tear reservoirs at the nasal, central, and temporal 
regions of the lower lid margin as well as removal of redundant conjunctival tissues (Fig. 3b).
Consistent with the findings on physical inspection, postoperative TMAs at all regions were significantly 
increased compared with the preoperative condition (P < .01, Fig. 4a; Supplemental Table 1). In addition, there 
were about two-fold improvements in not only the TBUT and CFS scores but also in the OSDI after surgical 
treatment for CCh (Fig. 4b, Supplemental Table 1). According to our multivariable analysis, postoperative symp-
tomatic relief scored by OSDI was independently determined by patients’ age and preoperative nasal LIPCOF 
(β =  − .335,.529 and P = .010, < .001, respectively) (Table 3). However, there were no changes in the MGD stage 
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and MGL grade between the pre- and postoperative statuses, and LLT was not also significantly increased after 
HFR-ES (72.43 ± 27.44 vs. 75.53 ± 26.58 nm) (Fig. 4b, Supplemental Table 1). These results were also confirmed 
using multivariable analysis, as shown in Table 3.
Figure 1.  Consecutive photographs of high-frequency radiowave electrosurgery for conjunctivochalasis. (a) 
After instillation of 0.5% proparacaine, the extent of the conjunctivochalasis (CCh) was determined using a 
cotton tip. (b–d) Using a fine insulated coated needle of the 4.0-MHz radiowave system, ablation of CCh was 
consecutively performed at the temporal, inferior, and nasal bulbar conjunctiva, causing a gradual change of 
the conjunctiva to a dusky white color (blanching) while lifting to prevent the sclera from thermal burns. (e) 
Ablation was also continued at the conjunctival fornix. (f) Finally, complete elimination of CCh was confirmed 
using a cotton tip.
Table 1.  Demographic characteristics of patients enrolled in the present study. All data are shown as the 
mean ± standard deviation. OSDI, ocular surface disease index; TBUT, Tear break-up time. CFS, corneal and 
conjunctival fluorescein staining based on Oxford schema; LIPCOF, Lid-parallel conjunctival folds; TMA, 
tear meniscus cross-sectional area; LLT, Lipid layer thickness; MGD, Meibomian gland dysfunction; MGL, 
Meibomian gland loss.
n = 40
Age, years (range) 61.65 ± 12.39 (34–82)
Sex, n (%), female 16 (40)
OSDI (range) 42.65 ± 19.88 (20.45–72.73)
TBUT, s (range) 1.83 ± 0.55 (1–3)
CFS score (range) 1.43 ± 0.50 (1–2)
LIPCOF score (range)
Nasal 2.28 ± 0.64 (1–3)
Central 0.85 ± 0.98 (0–3)
Temporal 2.10 ± 0.81 (1–3)
Total 5.23 ± 1.82 (3–9)
TMA, mm2 (range)
Nasal 0.0045 ± 0.0051 (0–0.015)
Central 0.0103 ± 0.0086 (0–0.024)
Temporal 0.0061 ± 0.0059 (0–0.015)
LLT, nm (range) 72.43 ± 27.44 (21–100)
MGD stage (range) 1.60 ± 1.53 (0–4)
MGL grade (range) 1.45 ± 1.36 (0–4)
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Discussion
In this study, we demonstrated that patients with CCh showed moderate to severe DED and most of them 
exhibited MGD. Particularly, OS disruption, tear instability, and MGD severity might be contributing factors to 
the exacerbation of CCh. HFR-ES for CCh was an effective modality for the anatomical correction of OS, and 
its effect on symptom relief was related to patient age and improvement of CCh in the nasal region. Moreover, 
it significantly ameliorated OS symptoms and signs, including OS disruption and tear film instability. However, 
MGD-related factors were not altered, even after CCh correction.
The exact pathological mechanism of CCh remains unclear, but several alterations of OS have been postulated. 
The first alteration is the senile degradation of the subconjunctival connective tissue, reducing attachment of the 
bulbar conjunctiva to the sclera and conjunctival  laxity2,14. A recent transcriptome analysis of human conjunctiva 
with CCh demonstrated that reduced gene expression could cause decreased cell viability, which is related to the 
aging  process26. The second is OS inflammation, which induces elastic fiber breakdown by destructive fibroblasts 
and infiltrated cells, resulting in initiating or accelerating  CCh13,14,27–29. Proinflammatory proteins also have been 
detected in tears of CCh  patients15,30–32. The third is oxidative stress including lipid peroxidation and DNA dam-
age in the chalatic conjunctiva, causing silent inflammation without recruitment of inflammatory  cells33. This 
Figure 2.  Correlation between the severity of conjunctivochalasis and ocular surface parameters. Among all 
ocular surface indexes, significant parameters related to each conjunctivochalasis (CCh) are shown with their 
coefficients (r) after the Spearman correlation analysis. (LIPCOF, lid-parallel conjunctival folds; OSDI, ocular 
surface disease index; CFS, corneoconjunctival fluorescein staining based on Oxford schema; TMA, tear film 
meniscus cross-sectional area measured by anterior segment optical computed tomography; TBUT, tear film 
break-up time; MGL, meibomian gland loss; MGD, meibomian gland dysfunction; LLT, lipid layer thickness).
Table 2.  Clinical parameters influencing severity of conjunctivochalasis in patients with dry eye disease. 
Significant values are presented in bold type. Each P-value was obtained via Spearman correlation analysis or 
stepwise multivariable regression analysis; r, Spearman’s correlation coefficient. SE, standard error; LIPCOF, 
Lid-parallel conjunctival folds; CFS, corneal and conjunctival fluorescein staining based on Oxford schema; 
TBUT, tear break-up time; MGD, Meibomian gland dysfunction; MGL, Meibomian gland loss; LLT, Lipid layer 
thickness.








P-value Adjusted  R2r P-value B SE β
LIPCOF score—total
CFS score .596 < .001 1.510 .335 .416 < .001 .719
TBUT − .729 < .001 − 1.437 .375 − .434 .001
MGD stage .685 < .001 0.263 .127 .222 .046
MGL grade .548 < .001 .010 .962
LLT  − .481 .001 .132 .326
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Figure 3.  Representative photographs of the surgical effect of high frequency radiowave electrosurgery for 
conjunctivochalasis. (a). At one month after high-frequency radiowave electrosurgery for conjunctivochalasis 
(CCh), complete elimination of CCh was confirmed using slit-lamp biomicroscopy. (b) Anterior segment 
optical computed tomography also identified recovery of tear reservoirs at the nasal, central, and temporal 
regions of the lower lid margin, as well as removal of redundant conjunctival tissue.
Figure 4.  Changes of ocular surface parameters following high-frequency radiowave electrosurgery 
for conjunctivochalasis. One month after high-frequency radiowave electrosurgery was performed for 
conjunctivochalasis, ocular surface indexes were compared between the preoperative and postoperative 
conditions using the Wilcoxon signed-rank test. Among all indexes, meaningful parameters are shown with 
their statistical significance. (a) Tear film meniscus cross-sectional areas measured by anterior segment optical 
computed tomography (TMA). (b) Ocular surface disease index (OSDI), tear film break-up time (TBUT), 
corneoconjunctival fluorescein staining based on Oxford schema (CFS), and lipid layer thickness (LLT). (**, 
P < .01; NS, not significant).
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can contribute to initiation of NF-κB and/or TNF-α signaling in the conjunctiva which can release cytokines in 
tears. Also, it can induce an increase in collagenolytic activity of conjunctival epithelial and stromal cells. Lastly, 
mechanical friction of the eyelids and completeness of the blink are also  causative7,16,34. Recently, researchers 
have categorized CCh into FRD as the one of DED  subtypes16,35. In addition, Pult et al. revealed that frequent 
partial blinks are significantly related to LIPCOF  grade7.
The association between CCh and DED is widely  accepted2. In the current work, patients with CCh displayed 
a co-existence of moderate to severe DED. Furthermore, CFS as OS disruption in DED was significantly corre-
lated with LIPCOF grades in all regions. This is consistent with another finding wherein CFS was a determinant 
of total CCh severity. Particularly, only nasal LIPCOF was significantly related to OSDI in our study. These results 
are supported by the findings of several previous  papers6,17,36 which suggested nasally located CCh was associ-
ated with higher DED symptoms. Specifically, Wang et al. demonstrated that symptoms as well as inflammation 
of tears and loss of goblet cells were more severe in patients with nasal CCh compared with eyes without nasal 
 CCh36. A positive relationship between CCh severity and DED symptoms has been  described9,20,37. In addition, a 
multicenter comparative study by Nemeth et al. also showed that the LIPCOF grade significantly correlated with 
subjective and objective signs of DED, even in various DED  subgroups8. Moreover, a recent population-based 
study proposed that CCh may be an independent risk factor for DED (odds ratio, 2.57)5.
The present findings showed that reduced TBUT was correlated with increase in central and temporal LIP-
COFs. CCh causes obliteration of the lower tear reservoir, imitating OS states like aqueous tear deficiency 
(ATD). Previous study demonstrated that TBUT in ATD combined with FRD like as CCh, was shorter than 
that of ATD patients without FRD regardless of whether MGD was  comorbid16. Furthermore, our multivariable 
analysis also indicated that shorter TBUT contributed to increase in CCh grade. Some studies have illustrated 
a decrease in soluble and membranous mucin, which affects TBUT, is associated with the severity of  CCh26,38. 
On the other hand, there was no relationship between TBUT and nasal LIPCOF but nasal LIPCOF was related 
to an increase in central TMA. This can be explained by delayed tear clearance with inferior punctal occlusion 
caused by nasal  CCh2,4.
Furthermore, we demonstrated that higher MGL grade, MGD stage, and lower LLT were significantly associ-
ated with severe CCh in all but the nasal region. However, among our MG-related parameters, only MGD stage 
independently predicted LIPCOF severity, whereas any measure of tear volume such as TMA was not correlated. 
Di Pascuale et al. reported that spatial correlation of CCh with anterior migration of the mucocutaneous junction 
was a feature of  MGD34. Regarding alterations of the location of Marx’s line, Pflugfelder et al. proposed that an 
anterior tear meniscus with concentrated osmolarity and inflammatory cytokines could affect differentiation of 
the MG orifices, causing squamous metaplasia of the lid  margin39.
In addition, our results showed a negative correlation between LLT and LIPCOF grade, even though the 
preoperative LLT in our cohort was relatively high (72.4 nm) compared to that in a previous report (49.6 nm)40. 
Because the LipiView II measures LLT at the lower cornea, LLT in CCh cases may be overestimated due to infe-
riorly stacking lipids, which in turn may be caused by inadequate spread of the tear layer. Insufficient meibum 
distribution into tears may lead to lipid tear deficiency (LTD), resulting in friction-related microtrauma and 
inflammation on the OS. In fact, in 1988, Meller and Tseng suggested that an unstable precorneal tear film in 
CCh patients might be caused by LTD rather than  ATD4. Collectively, it is probable that LTD with tear instability 
and OS disruption causes symptomatic CCh.
To date, it is well acknowledged that CCh surgical reconstruction of the tear meniscus as well as the tear 
reservoir can improve ocular symptoms and signs, including TBUT, tear osmolarity, inflammatory markers (i.e. 
matrix metalloproteinase-9), and contrast  sensitivity15,19,22,23,40. In the current study, there were consistent and 
significant improvements in OSDI, TBUT, and CFS even at one month after HFR-ES. Furthermore, this elec-
trosurgical approach may lead to significant recovery of TMAs at all regions. Consistent with our findings, Qiu 
et al. also reported that TMA increased significantly three months after use of the conjunctival excision  method23.
Table 3.  Multivariable regression analysis evaluating the effect of clinical variables on symptomatic 
improvement in dry eye patients following conjunctivochalasis correction. Significant values are presented in 
bold type. Each P-value was obtained via Spearman correlation analysis or stepwise multivariable regression 
analysis; r, Spearman’s correlation coefficient; SE, standard error; Δ, difference between postoperative and 
preoperative values. OSDI, ocular surface disease index; LIPCOF, Lid-parallel conjunctival folds; TMA, tear 
meniscus cross-sectional area; CFS, corneal and conjunctival fluorescein staining based on Oxford schema; 
LLT, Lipid layer thickness.








P-value Adjusted  R2r P-value B SE β
Δ OSDI
Age − .364 .011 − .454 .165 − .335 .009 .427
Preop. LIPCOF 
score—nasal .478 .001 13.860 3.257 .529 < .001
ΔTMA—temporal .451 .002 .178 .197
ΔCFS score .289 .035 .209 .088
Δ LLT  − .421 .003  − .106 .463
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According to other studies, postoperative Schirmer’s test results did not significantly change despite an 
improvement in patient  symptoms23,40. The authors of these studies suggested that ATD was not strongly asso-
ciated with symptoms in patients with CCh. Our data also showed changes in TMA were not independently 
associated with symptomatic improvements. Furthermore, there was no significant change in the MGL grade, 
LLT, and MGD stage between the pre- and post-operative statuses, indicating that LTD did not appear to be a 
major contributor to CCh symptoms. In support of this, our supplemental analysis suggested that only patient 
age and nasal LIPCOF were causatively related to preoperative OSDI and a decline in OSDI (Supplemental 
Table 2). Accordingly, symptomatic nasal CCh with a moderate or higher grade may be curable using only a 
surgical correction such as HFR-ES. In particular, younger patients with symptomatic CCh may have a stronger 
indication for surgery.
To date, 21 papers have introduced seven main types of surgical techniques for the treatment of CCh with 
or without DED (Supplemental Table 3). Of those, HFR-ES used in the current study generally has advantages 
of shorter operating time, better healing, avoidance of complications associated with sutures and scarring, and 
powerful cauterization without tissue  charring22,24,41. Therefore, our HFR-ES for CCh could achieve a significant 
improvement of OS symptom and signs despite the short postoperative period.
There are some limitations to this study. First, although other potential contributors to CCh exist, we were 
unable to investigate them. For instance, blinking, lid tension, or lid wiper epitheliopathy play a role in tear 
spread and clearance, thereby affecting the OS environment chemically and physically. Additionally, the relation-
ship between development of CCh and conjunctival fornixes, including the Kessing’s space (a tear reservoir), 
is unclear. Second, we did not inspect upper MGL grade and upper CCh, nor did we measure other objective 
indexes, including tear proteins or dynamics. Third, there was no control group for statistically analyzing baseline 
characteristics of enrolled patients. Lastly, the sample size and follow-up duration were limited. Accordingly, 
further large-scale studies with long-term observation should be conducted.
In conclusion, symptomatic CCh should be treated aggressively, since it is frequently accompanied by moder-
ate to severe DED as well as by MGD. Although CCh is found in chronologically aged conjunctiva, it is caused 
by OS disruption and lid friction with tear instability, both of which result from DED and/or MGD. HFR-ES for 
CCh is an effective modality for reconstruction of the lower tear meniscus and reservoir. In terms of indications 
of HFR-ES for CCh, clinicians should consider the patient age and CCh severity in the nasal region. Furthermore, 
management for MGD should be maintained after CCh correction.
Materials and methods
Patients. This prospective study followed the tenets of the Declaration of Helsinki, and the prospective 
study protocol was approved by the Severance Hospital Institutional Review Board, Seoul, South Korea (IRB No. 
4-2017-0362). We enrolled patients with CCh confirmed by slit-lamp biomicroscopy and AS-OCT, and ocular 
symptoms such as ocular discomfort, pain, foreign body sensation, and episodic tearing. Informed consent was 
obtained from all patients after explanation of the purpose and possible consequences of the study.
DED was diagnosed according to the Korean diagnostic criteria, as described  elsewhere42. The study cohort 
included patients who fulfilled the following diagnostic criteria: OSDI score > 12; TBUT < 5 s, or CFS based on 
Oxford schema ≥ 13,43. MGD was defined as (1) more than one lid margin abnormality, including irregularity, 
vascular engorgement, or anterior or posterior displacement of the mucocutaneous junction; (2) orifice obstruc-
tion such as plugging, pouting, or ridges; and (3) reduced meibum expression in response to moderate digital 
 pressure5,16,44.
We excluded patients younger than 20 years, those who wore contact lenses, and those with any ocular history 
even in one eye, ocular surgery, ocular injury, ocular infection, allergy, or autoimmune disease, as well as patients 
using a punctual plug or topical ophthalmic medications. Patients who used artificial tears were instructed not 
to apply them for at least 12 h before an examination. Only the test values for the right eye were analyzed.
Study protocol. After patients completed an OSDI questionnaire, clinical evaluations and automated meas-
urements were performed in the following order to minimize the effect of the previous measurement on other 
measurements: MGL grade and LLT by LipiView II (TearScience Inc., Morrisville, NC); TMA at the nasal, cen-
tral, and temporal regions of the lower lid margin by AS-OCT (RTVue, Optovue, Inc., Fremont, CA); LIPCOF 
score at the nasal, central, and temporal regions of the lower lid margin; CFS score; TBUT; and MGD staging. 
There was at least a 10-min interval between each test; all tests were performed in the same order. All clinical 
examinations were performed by one ophthalmologist (Y.W.J.), and the automated measurements were per-
formed by another ophthalmologist (H.K.).
The OSDI questionnaire is a validated 12-item questionnaire that assesses symptoms of ocular irritation 
consistent with DED, their impact on vision-related function, and environmental triggers. It gives a range of 0 
(no symptoms) to 100 (severe symptoms)45. LIPCOF (range, 0–3) was evaluated in the area perpendicular to 
the nasal, central, and temporal limbus on the bulbar conjunctiva above the lower lid (nasal LIPCOF, central 
LIPCOF, and temporal LIPCOF, respectively) with a slit-lamp microscope and classified using the optimized 
grading  scale8,10,37. A further combined LIPCOF score (total LIPCOF; range, 0–9) was calculated by adding the 
nasal, central, and temporal LIPCOF. The CFS score (range, 0–5) was derived using the Oxford  schema43, and tear 
film stability was determined by the TBUT using a sodium fluorescein strip (Haag-Streit, Koeniz, Switzerland). 
In terms of MGD staging, the examiner (Y.W.J) checked whether the following lid margin abnormalities were 
present: irregular lid margin, plugged MG orifices, vascular engorgement on the lid margin, and displacement of 
the mucocutaneous junction. Meibum expressibility was assessed on a scale of 0 to 3 in five glands in the lower 
lid, according to the number of glands expressible: 0, all five glands expressible; 1, three to four glands express-
ible; 2, one to two glands expressible; and 3, no gland expressible. Meibum quality was assessed in each of eight 
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glands of the central third of the lower lid on a scale of 0 to 3 for each gland: 0, clear; 1, cloudy; 2, cloudy with 
granular debris; and 3, thick, like toothpaste. The scores of the eight glands were summed to obtain a total score 
(0 to 24): MGD stage 1, minimally altered expressibility (= 1) and secretion quality (≥ 2 and < 4); MGD stage 2, 
mildly altered expressibility (= 1) and secretion quality (≥ 4 and < 8); MGD stage 3, lid margin features of plug-
ging, vascularity, and moderately altered expressibility (= 2) and secretion quality (≥ 8 and < 13); and MGD stage 
4, lid margin features of displacement, and severely altered expressibility (= 3) and secretion quality (≥ 13)46.
LLT was measured using a LipiView interferometer, as described by Blackie et al.47 LLT is presented in inter-
ferometric color units (ICU), where 1 ICU corresponds to approximately 1 nm. The maximum LLT value is 
limited to be 100 nm. The MGs were imaged using an infrared camera system equipped with LipiView II. MGL 
grade was evaluated using a meiboscale of the lower lid: grade 0, no gland loss; grade 1, area of gland loss < 25% 
of the total gland area; grade 2, area of gland loss between 25 and 50%; grade 3, area of gland loss 50–75%; and 
grade 4, area of gland loss > 75%. TMA was measured using the AS-OCT based on the Fourier-domain technique 
(RTVue)48; AS-OCT was evaluated in the area perpendicular to the nasal, central, and temporal limbus on the 
bulbar conjunctiva above the lower lid (nasal TMA, central TMA, and temporal TMA, respectively).
Surgical procedure of HFR‑ES. HFR-ES was performed by a single experienced surgeon (K.Y.S.) using a 
fine-needle electrode (Fine Insulated Coated Needle, 004 Super Fine) and the 4.0-MHz radiowave system (Ell-
man Surgitron Dual Frequency; Ellman International, Inc., Hewlett, NY)24,25. Briefly, after instillation of 0.5% 
proparacaine (Alcaine; Alcon Laboratories, Fort Worth, TX), the extent of the CCh was determined, and a fine-
needle electrode was inserted into the conjunctiva. The target conjunctiva was ablated while lifting to prevent 
the sclera from thermal burns or charring. Ablation was continued while retracting the electrode from the adja-
cent conjunctiva. All ablations were performed with the minimal power setting of 1 (of 100) in the coagulating 
mode, producing the least amount of lateral heat and tissue destruction. One to two seconds of ablation caused a 
gradual change in the conjunctiva to a dusky white color (blanching) (Fig. 1). Postoperatively, 0.5% levofloxacin 
(Cravit; Santen, Osaka, Japan) and 0.1% fluorometholone (Ocumetholone; Samil Pharmaceutical Co., Seoul, 
Korea) eye drops were initiated four times per day for 2 weeks.
Statistical analysis. We used SPSS for Windows (version 21.0; IBM Corp., Armonk, NY) for statistical 
analyses. Normality of distribution was checked using the Kolmogorov–Smirnov test. The Wilcoxon signed-
rank test was performed for comparison between pre- and post-operative values. Spearman’s correlation test 
confirmed the relationship between two values, with a correlation coefficient (r) of − 1 ≤ r ≤ 1. Stepwise mul-
tivariable linear regression analysis was applied to investigate the determinants of CCh severity or symptom 
relief following surgery, using criteria of probability-of-F-to-enter ≤ .05 and probability-of-F-to-remove ≥ .10. All 
regression model assumptions were evaluated by analyzing the condition index in the collinearity diagnostics 
to exclude the possibility of collinearity among the explanatory variables. The Durbin–Watson value was also 
investigated to confirm the independence of the residual errors. If the condition index was larger than 30, the 
last enrolled explanatory variable was excluded, and the other variables were included in the regression analy-
sis. Only modes with a condition index larger than zero and less than 30 and a Durbin–Watson test statistic of 
around 2 were included. In all statistical tests, a P-value less than 0.05 was considered statistically  significant49–52. 
Based on a priori power analyses using G * Power53,54 with preliminary results (n = 15; total predictors = 8 and 
tested predictors = 3), sample size of 40 achieved 85% power with a significance level (alpha) using a F test with 
post hoc analysis.
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